REQUEST A DEMO

Total

USD $0.00

View basket Checkout now

Search more companies

Enzybiotx Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Full name: Enzybiotx Sp. z o.o. Profile Updated: May 27, 2024

Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Enzybiotx Sp. z o.o. is a company based in Poland, with its head office in Gdynia. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on September 08, 2020. A negative growth of 30.31% was recorded in its total assets.

Headquarters
Ul. Al. Zwyciestwa 241/13
Gdynia; Pomorskie; Postal Code: 81-521

Contact Details: Purchase the Enzybiotx Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Enzybiotx Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Enzybiotx Sp. z o.o. report to view the information.

Incorporation Date:

September 08, 2020

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Supervisory Board Member

Purchase this report to view the information.

Supervisory Board Member

Purchase this report to view the information.

Supervisory Board Member

Purchase this report to view the information.

Supervisory Board Member

Ownership Details

Purchase this report to view the information.

38.83%

Purchase this report to view the information.

38.83%

Purchase this report to view the information.

19.42%

Company Performance

Financial values in the chart are available after Enzybiotx Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total operating revenue

16.68%▲

Operating profit (EBIT)

-111.19%▼

Net Profit (Loss) for the Period

-111.19%▼

Total assets

-30.31%▼

Total equity

-9.21%▼

Return on Equity (ROE)

-5.78%▼

Similar companies

"Novo Nordisk Pharma" Sp. z o.o.

Selvita Services Sp. z o.o.

Sartorius Stedim Poland Sp. z o.o.

Seasoil Biopolymers Sp. z o.o.

Helilab Sp. z o.o.

Henry Jones Sp. z o.o.

Cellis Sp. z o.o.

To view more information, Request a demonstration of the EMIS service

Buy this company report

Need ongoing access to company, industry or country information?

Request a demo